These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 11496541)

  • 1. [Primary systemic amyloidosis presenting as polymyalgia rheumatica and giant cell arteritis].
    Pantoja Zarza L; Paniagua De La Riva J; Megido Lahera M; Ortiz De Saracho J
    An Med Interna; 2001 Apr; 18(4):205-7. PubMed ID: 11496541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary systemic amyloidosis presenting as giant cell arteritis and polymyalgia rheumatica.
    Salvarani C; Gabriel SE; Gertz MA; Bjornsson J; Li CY; Hunder GG
    Arthritis Rheum; 1994 Nov; 37(11):1621-6. PubMed ID: 7980674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary amyloidosis associated with giant cell arteritis/polymyalgia rheumatica.
    Stebbing J; Buetens O; Hellmann D; Stone J
    J Rheumatol; 1999 Dec; 26(12):2698-700. PubMed ID: 10606387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple myeloma-associated amyloidosis and giant cell arteritis.
    Estrada A; Stenzel TT; Burchette JL; Allen NB
    Arthritis Rheum; 1998 Jul; 41(7):1312-7. PubMed ID: 9663490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary (AA-type) amyloidosis in patients with polymyalgia rheumatica.
    Escribá A; Morales E; Albizúa E; Herrero JC; Ortuño T; Carreño A; Dominguez-Gil B; Praga M
    Am J Kidney Dis; 2000 Jan; 35(1):137-40. PubMed ID: 10620555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Simultaneous multiple myeloma and giant cell arteritis without systemic amyloidosis].
    Finn BC; Young P; Silva ED; Bruetman JE; Bottaro FJ; Venditti JE; Shanley CM; Ceresetto J; Bullorsky E
    Medicina (B Aires); 2006; 66(6):555-7. PubMed ID: 17240628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homocysteine levels in polymyalgia rheumatica and giant cell arteritis: influence of corticosteroid therapy.
    Martinez-Taboada VM; Bartolome MJ; Fernandez-Gonzalez MD; Blanco R; Rodriguez-Valverde V; Lopez-Hoyos M
    Rheumatology (Oxford); 2003 Sep; 42(9):1055-61. PubMed ID: 12730520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Giant cell arteritis and renal amyloidosis: report of a case.
    Moraga ; Sicilia JJ; Blanco J; Ubeda I
    Clin Nephrol; 2001 Nov; 56(5):402-6. PubMed ID: 11758014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Jaw claudication in primary amyloidosis: unusual presentation of a rare disease.
    Churchill CH; Abril A; Krishna M; Callman ML; Ginsburg WW
    J Rheumatol; 2003 Oct; 30(10):2283-6. PubMed ID: 14528530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymyalgia rheumatica and giant cell arteritis--An ophthalmic emergency.
    Durkin SR; Athanasiov PA; Crompton JL
    Aust Fam Physician; 2006 Nov; 35(11):889-91. PubMed ID: 17099810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do steroids increase lymphoma risk? A case-control study of lymphoma risk in polymyalgia rheumatica/giant cell arteritis.
    Askling J; Klareskog L; Hjalgrim H; Baecklund E; Björkholm M; Ekbom A
    Ann Rheum Dis; 2005 Dec; 64(12):1765-8. PubMed ID: 15843445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Polymyalgia rheumatica and giant cell arteritis--first results of a year-long study].
    Rovenský J; Tuchynová A; Poprac P; Blazíková S; Bosák V; Stvrtinová V
    Vnitr Lek; 2006; 52(7-8):691-6. PubMed ID: 16967610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary AL (kappa-light chain) amyloidosis manifesting as peripheral neuropathy in a young male without increase in serum and urine immunoglobulin load: a diagnostic challenge.
    Sarkar C; Chand Sharma M; Nayak A; Mercy Ralte A; Gupta V; Singh S; Behari M
    Clin Neuropathol; 2005; 24(3):118-25. PubMed ID: 15943163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Giant cell arteritis without clinically evident vascular involvement in a defined population.
    Gonzalez-Gay MA; Garcia-Porrua C; Amor-Dorado JC; Llorca J
    Arthritis Rheum; 2004 Apr; 51(2):274-7. PubMed ID: 15077272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low serum levels of DHEAS in untreated polymyalgia rheumatica/giant cell arteritis.
    Narváez J; Bernad B; Díaz Torné C; Momplet JV; Montpel JZ; Nolla JM; Valverde-García J
    J Rheumatol; 2006 Jul; 33(7):1293-8. PubMed ID: 16783861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Giant cell arteritis and polymyalgia rheumatica: role of cytokines in the pathogenesis and implications for treatment.
    Martinez-Taboada VM; Alvarez L; RuizSoto M; Marin-Vidalled MJ; Lopez-Hoyos M
    Cytokine; 2008 Nov; 44(2):207-20. PubMed ID: 18986814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical aspects of multiple myeloma and related disorders including amyloidosis.
    Kyle RA
    Pathol Biol (Paris); 1999 Feb; 47(2):148-57. PubMed ID: 10192881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Giant cell arteritis and polymyalgia rheumatica as first manifestation of typical pulmonary carcinoid tumor.
    Aguiar T; Vincent MB
    Reumatismo; 2015 Dec; 67(4):165-8. PubMed ID: 27215183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary amyloidosis (AL) presenting with nephrotic syndrome: a case report and discussion.
    Musolin L; Reyna R; DeBord J
    W V Med J; 2003; 99(1):28-30. PubMed ID: 12762214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AL amyloidosis with temporal artery involvement simulates giant-cell arteritis.
    Audemard A; Boutemy J; Galateau-Salle F; Macro M; Bienvenu B
    Joint Bone Spine; 2012 Mar; 79(2):195-7. PubMed ID: 22209315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.